Cancer Institute Hospital of JFCR - Dept of Respiratory Medicine

Kōtoku 135-8550

0 studies enrolling now · 3 studies all time

What they study most

Non-small Cell Lung Cancer, Solid Tumors

Studies at this site

• Avelumab Program Rollover Study — Running, not enrolling
• M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC) — Completed
• M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) — Stopped early